Dr. Reddy's Signs Agreement with Gilead for HIV Drug
Hyderabad: Dr. Reddy's Laboratories is strengthening its HIV drug portfolio. As part of this initiative, the company plans to manufacture 'Lenacapavir,' a drug that prevents HIV infection with just a once-yearly administration. It has entered into an agreement with the global pharmaceutical giant Gilead Sciences to acquire the necessary technology for this purpose. This drug, developed by Gilead, is already in the human trial stage.
You Might Also Like
-
Hyderabad: Dr. Reddy's Laboratories is strengthening its HIV drug portfolio. As part of this init...
-
Mumbai: Tata Motors has raised the prices of its commercial vehicles by 1 percent. The company an...
Leave A Comment
Comments